Petros Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
Petros Pharmaceuticals, Inc. (PTPI) reported Increase (Decrease) in Prepaid Expense and Other Assets of $30.25 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was $15.12K, a 31.06% decline year-over-year.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $15.12K, a 71.20% decline year-over-year.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$36.33K.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$12.14K.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $25.99K.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$35.31K.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$215.03K.
- Petros Pharmaceuticals, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$1.65M, a 327.41% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $30.25K 10-Q · filed 2026-08-13 | -$6.08K derived: sum of 3 quarters · filed 2026-08-13 | -$18.22K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $15.12K 10-Q · filed 2026-05-13 | -$21.20K derived: sum of 2 quarters · filed 2026-05-13 | -$33.34K derived: sum of 3 quarters · filed 2026-05-13 | -$11.40K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$36.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$48.47K derived: sum of 2 quarters · filed 2026-04-15 | -$26.53K derived: sum of 3 quarters · filed 2026-08-13 | $25.99K 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | -$12.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.80K derived: sum of 2 quarters · filed 2026-08-13 | $62.32K 10-Q · filed 2025-11-13 | $1.77K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $21.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $74.46K 10-Q · filed 2026-08-13 | $13.91K derived: sum of 3 quarters · filed 2026-08-13 | $4.72K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $52.52K 10-Q · filed 2026-05-13 | -$8.02K derived: sum of 2 quarters · filed 2026-05-13 | -$17.22K derived: sum of 3 quarters · filed 2026-05-13 | -$23.76K derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | -$60.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$69.74K derived: sum of 2 quarters · filed 2026-04-15 | -$76.28K derived: sum of 3 quarters · filed 2026-04-15 | -$35.31K 10-K · filed 2026-04-15 | -$1.63M 10-K · filed 2025-03-31 | |||
| 2024-09-30 | -$9.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$15.73K derived: sum of 2 quarters · filed 2025-11-13 | $25.24K 10-Q · filed 2025-11-13 | -$1.39M 10-Q · filed 2024-11-13 | $169.70K derived: sum of 4 quarters · filed 2025-11-13 | |||
| 2024-06-30 | -$6.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $34.43K 10-Q · filed 2025-08-14 | -$845.99K 10-Q · filed 2024-08-14 | $178.89K derived: sum of 3 quarters · filed 2025-08-14 | $146.39K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | $40.97K 10-Q · filed 2025-05-15 | -$151.16K 10-Q · filed 2024-05-15 | $185.43K derived: sum of 2 quarters · filed 2025-05-15 | $152.93K derived: sum of 3 quarters · filed 2025-05-15 | $6.17K derived: sum of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | $144.46K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $111.96K derived: sum of 2 quarters · filed 2025-03-31 | -$34.80K derived: sum of 3 quarters · filed 2025-03-31 | -$215.03K 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$32.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$179.25K derived: sum of 2 quarters · filed 2024-11-13 | -$359.49K 10-Q · filed 2024-11-13 | -$529.48K derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | -$146.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$326.99K 10-Q · filed 2024-08-14 | -$496.98K derived: sum of 3 quarters · filed 2024-08-14 | -$916.91K derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | -$180.24K 10-Q · filed 2024-05-15 | -$350.22K derived: sum of 2 quarters · filed 2024-05-15 | -$770.16K derived: sum of 3 quarters · filed 2024-05-15 | -$1.59M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | -$169.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$589.92K derived: sum of 2 quarters · filed 2024-04-01 | -$1.41M derived: sum of 3 quarters · filed 2024-04-01 | -$1.65M 10-K · filed 2024-04-01 | ||||
| 2022-09-30 | -$419.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | -$1.24M derived: sum of 2 quarters · filed 2023-11-15 | -$1.48M 10-Q · filed 2023-11-15 | -$673.62K derived: sum of 4 quarters · filed 2023-11-15 | ||||
| 2022-06-30 | -$820.83K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$1.06M 10-Q · filed 2023-08-14 | -$253.68K derived: sum of 3 quarters · filed 2023-08-14 | -$248.47K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | -$237.50K 10-Q · filed 2023-05-15 | $567.15K derived: sum of 2 quarters · filed 2023-05-15 | $572.36K derived: sum of 3 quarters · filed 2023-05-15 | $659.33K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $804.65K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | $809.87K derived: sum of 2 quarters · filed 2023-03-31 | $896.84K derived: sum of 3 quarters · filed 2023-03-31 | $724.78K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $5.22K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | $92.19K derived: sum of 2 quarters · filed 2022-11-15 | -$79.86K 10-Q/A · filed 2022-11-15 | -$75.29K 10-Q · filed 2021-11-15 | -$263.38K derived: sum of 4 quarters · filed 2022-11-15 | |||
| 2021-06-30 | $86.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$85.08K 10-Q · filed 2022-08-12 | -$80.50K 10-Q · filed 2021-08-16 | -$268.60K derived: sum of 3 quarters · filed 2022-08-12 | $795.16K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | -$172.05K 10-Q · filed 2022-05-16 | -$355.57K derived: sum of 2 quarters · filed 2022-05-16 | $708.19K derived: sum of 3 quarters · filed 2022-05-16 | $106.20K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$183.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $880.24K derived: sum of 2 quarters · filed 2022-03-31 | $278.25K derived: sum of 3 quarters · filed 2022-03-31 | -$1.03M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $1.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $461.76K derived: sum of 2 quarters · filed 2021-11-15 | -$847.59K 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | -$601.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$1.91M 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | -$1.31M 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |